Search Results - "Sandbach, J F"

Exercise-induced fragmentation hemolysis : A simple in vivo test to evaluate heart valve hemolysis by KAMPE, C. E, RODGERS, G. P, OSWALT, J. D, SANDBACH, J. F

“…Differentiating heart valve-related fragmentation hemolysis from other causes of hemolysis can occasionally be difficult, especially when findings on…”
Get full text

Prospective clinical trial of a human tumor cloning system by Von Hoff, D D, Clark, G M, Stogdill, B J, Sarosdy, M F, O'Brien, M T, Casper, J T, Mattox, D E, Page, C P, Cruz, A B, Sandbach, J F

“…A prospective clinical trial was performed to evaluate the usefulness of a human tumor cloning system for selecting single-agent chemotherapy for patients with…”
Get full text

Extraneural metastases from medulloblastoma: long-term survival after sequentially scheduled chemotherapy and radiotherapy by Mahoney, Jr, D H, Steuber, C P, Sandbach, J F, Fernbach, D J

“…Extraneural relapse of medulloblastoma is an uncommon event which has typically been associated with a fatal outcome. We present a case of a 2 1/2-year-old…”
Get more information

A phase II study of weekly docetaxel and carboplatin in stage IIIB (with effusion) or stage IV non-small cell lung cancer patients age < 65 and performance status 2 by Sandbach, J. F., Weissman, C., Brooker, R., Ilegbodu, D., Asmar, L.

“…Abstract only…”
Get full text

A phase II study of weekly docetaxel and carboplatin in stage IIIB (with effusion) or stage IV non-small cell lung cancer patients age < 65 and performance status 2 by Sandbach, J. F., Weissman, C., Brooker, R., Ilegbodu, D., Asmar, L.

“…Abstract only…”
Get full text

A phase II study of weekly docetaxel and carboplatin in stage IIIB (with effusion) or stage IV non-small cell lung cancer patients age <65 and performance status 2 by Weissman, C. H., Sandbach, J. F., Brooker, R. J., Ilegbodu, D., Asmar, L.

“…Abstract only…”
Get full text

A phase II study of weekly docetaxel and carboplatin in stage IIIB (with effusion) or stage IV non-small cell lung cancer patients age <65 and performance status 2 by Weissman, C. H., Sandbach, J. F., Brooker, R. J., Ilegbodu, D., Asmar, L.

“…Abstract only…”
Get full text

Phase I clinical investigation of 9,10-anthracenedicarboxaldehyde bis[(4,5-dihydro-1 H-imidazol-2-yl)hydrazone] dihydrochloride (CL216,942) by Von Hoff, D D, Myers, J W, Kuhn, J, Sandbach, J F, Pocelinko, R, Clark, G, Coltman, Jr, C A

“…9,10-Anthracenedicarboxaldehyde bis[(4,5-dihydro-1 H-imidazol-2-yl)hydrazone] dihydrochloride (CL216,942) is a new anthracene bishydrazone derivative that was…”
Get full text

Selection of cancer chemotherapy for a patient by an in vitro assay versus a clinician by Von Hoff, D D, Sandbach, J F, Clark, G M, Turner, J N, Forseth, B F, Piccart, M J, Colombo, N, Muggia, F M

“…One hundred thirty-three patients with advanced metastatic cancer were randomized to receive single-agent chemotherapy selected by either a medical oncologist…”
Get more information

Anaphylactoid reactions associated with bisantrene infusions by Myers, J W, Von Hoff, D D, Kuhn, J G, Osborne, C K, Sandbach, J F, Pocelinko, R

“…Nine of ninety-three patients receiving Bisantrene on an every three week schedule developed an anaphylactoid reaction with a variety of symptoms. Most…”
Get full text